CRY CryoLife Inc

ATLANTA, Feb. 13 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), a biomaterials, medical device and tissue processing company, announced today that it is scheduled to participate in the Roth Capital Partners 20th Annual OC Growth Stock Conference, February 19, 2008 at the Ritz Carlton Laguna Niguel in Dana Point, Calif. D. Ashley Lee, executive vice president, chief operating officer and chief financial officer of CryoLife, Inc., will present Tuesday, February 19 at 8:30 a.m., Pacific Time. CryoLife's live presentation may be accessed through its Web site, http://www.cryolife.com/, on the Investor Relations page. An archived copy of the presentation will be available for 90 days on the same Web site. About CryoLife Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company recently received FDA clearance for its CryoValve(R) SG pulmonary human heart valves, processed using CryoLife's proprietary SynerGraft(R) Technology. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community. For additional information about the Company, visit CryoLife's Web Site: http://www.cryolife.com/. Media Contacts: D. Ashley Lee Katie Brazel Executive Vice President, Chief Financial Officer Fleishman Hillard and Chief Operating Officer Phone: 770-419-3355 Phone: 404-739-0150 DATASOURCE: CryoLife, Inc. CONTACT: D. Ashley Lee, Executive Vice President, Chief Financial Officer and Chief Operating Officer, +1-404-739-0150; or Katie Brazel, Fleishman Hillard, +1-770-419-3355 Web site: http://www.cryolife.com/

Copyright